Potenza Therapeutics, Inc.

Venture-backed company · Stage unknown· MA
Rounds on record
2
Latest round
Dec 19, 2017
Form D equity offering
Latest round size
$5.0M
As of · the latest observation of this company; each round carries its own date

What matters now

  1. 1 investor
    named

    1 investor on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
Drawing the relationship network…

Facts

Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1

Financing history

2 rounds
  1. Dec 19, 2017
    Form D equity offering · $5.0M (form d sold)
    MPM Bioimpact via Luke Basil Evnin
    Fact Form D · “Potenza Therapeutics, Inc. Form D, first filed 2017-12-29”
  2. Dec 2, 2014
    Form D equity offering · $15.0M (form d sold)
    MPM Bioimpact via Luke Basil Evnin
    Fact Form D · “Potenza Therapeutics, Inc. Form D, first filed 2014-12-05”

Investors on record

2 edges

Ownership and outcomes

none on record
Outcome stated by investors

No firm portfolio page lists this company, so no outcome is stated.

No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

0 officers, 0 directors
No officer or director on record.

Timeline

0 events
No dated event on record.

Evidence

0 observations
Every observation on this company

    Relationships across DFX

    on 1 other DFX graph
    Across the graphs

    Potenza Therapeutics, Inc. is the same institution as 1 record in Private Equity.

    Private Equity1

    The joined record opens with the product, beside every other relationship on this page.

    Checking your plan…